Skip to content

Fetal Cardiac Function

Fetal Systolic and Diastolic Cardiac Function Assessment in Mothers with Preeclampsia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06381258
Enrollment
72
Registered
2024-04-24
Start date
2024-04-30
Completion date
2024-12-12
Last updated
2024-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Growth Retardation

Brief summary

The aim of our study is to evaluate the effect of PE and FGR on fetal cardiac function. Pregnancies with preeclampsia and FGR, and preeclampsia with normal fetal growth are evaluated by echocardiography and compared with uncomplicated pregnancies.

Detailed description

Preeclampsia (PE) represent a major concern in public health, affecting 2-8% of all pregnancies and considered one of the leading causes of perinatal morbidity and mortality. Fetal growth restriction (FGR) ia also a common health problem affecting about 5-10% of all pregnancies and commonly associates with preeclampsia . It is estimated that 20% of cases of PE present with FGR and about 50% of early-onset FGR cases will eventually coexist with PE . Both syndromes share some pathophysiologic features, with a variable involvement of placental insufficiency and cause fetal cardiovascular remodeling and adaptations . Fetal adaptations as metabolic and cardiovascular programming occur in response to adverse intrauterine conditions as PE and FGR . Offspring from preeclamptic pregnancies showed cardiac structural and functional changes and greater blood pressure in childhood and adolescence . Most of the studies on FGR included pregnancies complicated by PE and vice versa, which fails to adequately assess the independent effect of each condition on the fetal cardiac functions.

Interventions

PROCEDUREUltrasound

Fetal echocardiography using ultrasound device

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Pregnant women more than or equals 28 weeks * Preeclampsia defined as systolic blood pressure 140 mm Hg and/or diastolic blood pressure 90 mm Hg * Fetus with normal growth or with growth restriction

Exclusion criteria

* congenital malformations * intrauterine infection * multiple pregnancies * fetuses of mothers treated with a tocolytic agent * fetuses with abnormal heart rates (tachycardia or bradycardia)

Design outcomes

Primary

MeasureTime frameDescription
Cardiac systolic function4 monthsMeasurement of ejection fraction in percent % (high is good, low is bad)

Secondary

MeasureTime frameDescription
Cardiac diastolic function4 monthsMeasurement of spherity index ( high is bad, low is good)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026